Related Experiment Video
Updated: Jan 8, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
Extrachromosomal circular miRNA-gene amplifications contribute to the renal cancer phenotype
1Scientific Research Center, Department of Urology, Pelvic Floor Disorders Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong 518107, China; Department of Biology, University of Copenhagen, 2100 Copenhagen, Denmark; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
Abstract:
Megabase-sized extrachromosomal circular DNA with intact oncogenes (ecDNA) plays crucial roles in cancer. However, the impact of smaller (100 bp-1 Mb), more ubiquitous extrachromosomal circular DNA (eccDNA) on tumor pathology is unclear. We analyze eccDNA from 122 renal tumors and adjacent tissues, finding increased eccDNA in late-stage cancers, correlating with heightened patient mortality and copy-number amplification. Large eccDNAs are rare, and smaller eccDNAs predominate. The microRNA (miRNA) genes MIR107, MIR196a, MIR495, and MIR519 are recurrently found on eccDNA, almost exclusively in tumors, and patients with any one of these exhibited shorter progression-free survival. Synthetic eccDNAs with these MIR genes increase cancer cell proliferation in 786-O cells, suggesting oncogenic potential. Additionally, we found eccDNA carrying full protein-coding genes that are overexpressed in transcriptional analyses. Our findings suggest that small eccDNAs with miRNA genes are functional and contribute to the tumorigenesis of renal cell carcinoma.
Insights
Smaller extrachromosomal circular DNA (eccDNA) is more common in late-stage kidney cancer, linked to worse survival. Specific microRNA genes on eccDNA promote cancer cell growth, suggesting a role in tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Extrachromosomal circular DNA (ecDNA) is implicated in cancer, but the role of smaller, more abundant eccDNA is unknown.
- Renal cell carcinoma (RCC) is a significant health concern, necessitating further understanding of its molecular underpinnings.
Purpose of the Study:
- To investigate the role of small eccDNA in renal tumors.
- To determine the association between eccDNA and RCC progression and patient outcomes.
Main Methods:
- Analysis of eccDNA from 122 renal tumors and adjacent tissues.
- Correlation analysis of eccDNA levels with cancer stage, patient mortality, and copy-number amplification.
- Identification and functional assessment of miRNA genes on eccDNA.
Main Results:
- Increased eccDNA abundance in late-stage RCC, correlating with poorer survival and copy-number amplification.
- Recurrent presence of specific miRNA genes (MIR107, MIR196a, MIR495, MIR519) on tumor eccDNA, associated with shorter progression-free survival.
- Synthetic eccDNAs carrying these miRNA genes enhanced proliferation in RCC cells, indicating oncogenic potential.
Conclusions:
- Small eccDNAs, particularly those harboring miRNA genes, are functional and contribute to renal cell carcinoma tumorigenesis.
- eccDNA represents a potential therapeutic target and biomarker in RCC.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Cancers Originate from Somatic Mutations in a Single Cell
MicroRNAs
MicroRNAs
Induced Pluripotent Stem Cells
Somatic...

